In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Compugen Ltd.. Trade Record

NASDAQ:CGEN Compugen Ltd. stock gains 9.21% Exit Jan 31, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CGEN Jan 17, 2018, priceSeries
About Compugen Ltd.

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company's pipeline primarily includes early and preclinical stage immuno-oncology programs based on novel drug targets, such as immune checkpoint and myeloid protein target candidates to harness the immune system to provide treatment solutions in the areas of unmet medical needs in various cancer types and patient populations. Its antibody drug conjugate target candidates comprise CGEN-15001T, CGEN-15022, CGEN-15029, and CGEN-15137 for oncology; and therapeutic proteins include CGEN-15001, a fusion protein for autoimmune diseases, as well as CGEN myeloid target. The company was incorporated in 1993 and is headquartered in Holon, Israel.

Trade Information
Trade Type
LONG
ReliabilityScore™
88.69
Entry Date
Jan 17, 2018
Entry Price
2.75
Sell Date
Jan 31, 2018
Sell Price
3.00
Net Gain
9.21%
Hold Time
10 Trading Days